Literature DB >> 1206104

Normalization of fasting hyperglucagonemia and excessive glucagon responses to intravenous arginine in human diabetes mellitus by prolonged infusion of insulin.

J E Gerich, E Tsalikian, M Lorenzi, V Schneider, N V Bohannon, G Gustafson, J H Karam.   

Abstract

Infusion of insulin (1 U/hr) for 14 hr suppressed basal glucagon levels and normalized previously excessive glucagon responses to arginine in juvenile-onset, insulin-dependent diabetic subjects, indicating that abnormal pancreatic alpha-cell function in human juvenile-onset diabetes mellitus may be a consequence of insulin lack.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1206104     DOI: 10.1210/jcem-41-6-1178

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  17 in total

1.  Diminished glucagon suppression after β-cell reduction is due to impaired α-cell function rather than an expansion of α-cell mass.

Authors:  Juris J Meier; Sandra Ueberberg; Simone Korbas; Stephan Schneider
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-02-01       Impact factor: 4.310

Review 2.  Glucagon and diabetes: a reappraisal.

Authors:  P J Lefebvre; A S Luyckx
Journal:  Diabetologia       Date:  1979-06       Impact factor: 10.122

3.  Effects of somatostatin added to insulin in a glucose-controlled insulin infusion system.

Authors:  J L Selam; D Chenon; T C Pham; J P Gagnol; C Sany; N Thomas; G Gravagne; A Orsetti; J Mirouze
Journal:  Diabetologia       Date:  1981-08       Impact factor: 10.122

Review 4.  Alpha cell function in health and disease: influence of glucagon-like peptide-1.

Authors:  B E Dunning; J E Foley; B Ahrén
Journal:  Diabetologia       Date:  2005-08-13       Impact factor: 10.122

5.  Dose-kinetics of pancreatic glucagon responses to arginine and glucose in subjects with normal and impaired pancreatic B cell function.

Authors:  R Assan; S Efendic; R Luft; E Cerasi
Journal:  Diabetologia       Date:  1981-11       Impact factor: 10.122

6.  Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM.

Authors:  S Dinneen; A Alzaid; D Turk; R Rizza
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

7.  Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes: implications for therapy.

Authors:  Robert A Rizza
Journal:  Diabetes       Date:  2010-08-12       Impact factor: 9.461

8.  Insulin signaling in alpha cells modulates glucagon secretion in vivo.

Authors:  Dan Kawamori; Amarnath J Kurpad; Jiang Hu; Chong Wee Liew; Judy L Shih; Eric L Ford; Pedro L Herrera; Kenneth S Polonsky; Owen P McGuinness; Rohit N Kulkarni
Journal:  Cell Metab       Date:  2009-04       Impact factor: 27.287

9.  Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus.

Authors:  J E Gerich; M Langlois; C Noacco; M Lorenzi; J H Karam; P H Korsham
Journal:  J Clin Invest       Date:  1976-08       Impact factor: 14.808

10.  Comparison of somatostatin distribution in pancreatic duct ligated rats and streptozotocin diabetic rats.

Authors:  W Lee; H Wakasugi; H Ibayashi
Journal:  Gastroenterol Jpn       Date:  1983-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.